Excited to see our paper published by @CDCMMWR!
Great collaboration with the amazing @EhudR4 🙏
We showed the population-level effectiveness of COVID-19 vaccination in preventing severe disease requiring mechanical ventilation.
Short explainer👇 1/n bit.ly/MMWR22621
We analysed the publicly available COVID-19 vaccination and cases data from Israel, and compared the daily number of ventilated patients in the highly vaccinated >70 age group with the under-50 age group (low vaccine coverage).
2/n
The ratio of COVID-19 patients over 70 years old to patients under 50 years old requiring mechanical ventilation decreased by 67% as compared with rates before the vaccination program.
3/n
The time frame included the Oct 2020 and the Dec-Jan 2021 surge in COVID-19 in Israel. Before vaccination campaign started, over-70’s requiring mechanical ventilation outnumbered under-50 age group by about 6:1.
By the first week of Feb this was down to less than 2:1
4/n
There are limitations to our study which we detailed in the article. For instance, a possible explanation may be stricter adherence to mitigation by the older age group (strict lockdown instituted in Israel on Jan 8).
We didn't see this reduction in ratio during Oct lockdown
5/n
Our hypothesis of vaccine protection from severe COVID is in agreement with by all of the other amazing research that was published on vaccine effect in Israel:
6/n
#COVID in Israel, thread with some possible explanations.
Within the last 4wks: 1. Massive vaccination campaign, with ~80% of the >60 population vaccinated. 2. A third national lockdown declared. 3. Huge surge in cases and deaths. @EricTopol and others ask "what is going on?" 1/5
The question being, why have we yet to see a positive effect of both these dramatic measures?
Here are some important points to consider in this regard. 1. The vaccine campaign (correctly) targeted at-risk individuals, mainly the over-60 population.
2/5
2. Yet the drivers of the infection wave are the younger population, who have not been vaccinated up till now (rollout for younger people starting this week!). 3. The vaccination campaign is a success. But vacc % are low in some high-morbidity communities. See plot: 3/5